Microaxial flow pump does not improve outcomes for high-risk heart attack patients without cardiogenic shock: Trial

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage. That is the major finding from the first clinical trial of its kind to analyze the effect of resting the heart in high-risk heart attack patients to see if it reduces the size of the heart attack.